Evidence map›Paper›PMID 27668169›Full record

ReviewApplied & translational genomics2016

Standardization and quality management in next-generation sequencing.

Christoph Endrullat, Jörn Glökler, Philipp Franke, Marcus Frohme

Registry-linked trialAbstract readReview
In one paragraph

Review in Applied & translational genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03892577 (Real-world Study for Targeted Therapy and Immunotherapy in Patients With Advanced Hepatobiliary Tumors), which is not on this map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03892577 unknown statusnot on this mapstarted 2017, after this paper: background citation

Real-world Study for Targeted Therapy and Immunotherapy in Patients With Advanced Hepatobiliary Tumors: a Multi-centers, Open-assess Observational Study.

Typeobservational_patient_registrySponsorPeking Union Medical College HospitalRan2017 to 2025Enrolled3,000ConditionsObjective Response Rate, Progression-free Survival, Overall Survival, Disease Control RateArmsPrecision oncology including targeted therapy and immunotherapy
3 · Its place in the literature

Who cites it

92 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Targeted Amplicon Genotyping by Sanger Sequencing.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christoph EndrullatMolecular Biotechnology and Functional Genomics, Institute of Applied Biosciences, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany.
Jörn GlöklerMolecular Biotechnology and Functional Genomics, Institute of Applied Biosciences, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany.
Philipp FrankeMolecular Biotechnology and Functional Genomics, Institute of Applied Biosciences, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany.
Marcus FrohmeMolecular Biotechnology and Functional Genomics, Institute of Applied Biosciences, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA sequencing continues to evolve quickly even after > 30 years. Many new platforms suddenly appeared and former established systems have vanished in almost the same manner. Since establishment of next-generation sequencing devices, this progress gains momentum due to the continually growing demand for higher throughput, lower costs and better quality of data. In consequence of this rapid development, standardized procedures and data formats as well as comprehensive quality management considerations are still scarce. Here, we listed and summarized current standardization efforts and quality management initiatives from companies, organizations and societies in form of published studies and ongoing projects. These comprise on the one hand quality documentation issues like technical notes, accreditation checklists and guidelines for validation of sequencing workflows. On the other hand, general standard proposals and quality metrics are developed and applied to the sequencing workflow steps with the main focus on upstream processes. Finally, certain standard developments for downstream pipeline data handling, processing and storage are discussed in brief. These standardization approaches represent a first basis for continuing work in order to prospectively implement next-generation sequencing in important areas such as clinical diagnostics, where reliable results and fast processing is crucial. Additionally, these efforts will exert a decisive influence on traceability and reproducibility of sequence data.

Indexed as

ABRF, Association of Biomolecular Resource FacilitiesBAM, binary alignment/mapCAP, College of American Pathologist'sCEN, European Committee for StandardizationCLIA, Clinical Laboratory Improvement AmendmentsData qualityddPCR, digital droplet PCRERCC, External RNA Controls ConsortiumFDA, Food and Drug AdministrationFFPE, formalin-fixed, paraffin-embeddedFMEA, failure mode and effects analysisGATK, genome analysis toolkitGSC, Genomic Standards ConsortiumGuidelineHGP, Human Genome ProjectIndel, insertion or deletionMAQC, MicroArray Quality Control ProjectMIGS, minimum information about a genome sequenceMOL, molecular pathology checklistmtDNA, mitochondrial DNANex-StoCT, next generation sequencing — standardization of clinical testingNext-generation sequencingNGS, next-generation sequencingNIST, National Institute of Standards and TechnologyNTC, no-template controlPT, proficiency testingQA, quality assuranceQC, quality controlQM, quality managementQMS, quality management systemqPCR, quantitative PCRQuality managementRIN, RNA integrity numberSAM, sequence alignment/mapSEQC, sequencing quality controlSNP, single nucleotide polymorphismSOP, standard operating procedureStandardizationTN, technical noteValidationVCF, variant call format

Identifiers

PMID27668169
PMCPMC5025460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.